Debabrata Mukherjee

Debabrata Mukherjee

Texas Tech University

H-index: 81

North America-United States

About Debabrata Mukherjee

Debabrata Mukherjee, With an exceptional h-index of 81 and a recent h-index of 45 (since 2020), a distinguished researcher at Texas Tech University, specializes in the field of Cardiovascular Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Insights Into Differences in Pulmonary Hemodynamics in Hispanic Patients With Pulmonary Arterial Hypertension

Anticoagulation in the Management of Acute Pulmonary Embolism—A Review

Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?

Statins and Venous Thromboembolic Disease-Where are we Now?

Reduced-Dose Thrombolysis for Acute Pulmonary Embolism

Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review

Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial Entity

Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review

Debabrata Mukherjee Information

University

Position

Texas Tech University Health Sciences Center

Citations(all)

85099

Citations(since 2020)

42008

Cited By

69440

hIndex(all)

81

hIndex(since 2020)

45

i10Index(all)

373

i10Index(since 2020)

169

Email

University Profile Page

Google Scholar

Debabrata Mukherjee Skills & Research Interests

Cardiovascular Diseases

Top articles of Debabrata Mukherjee

Insights Into Differences in Pulmonary Hemodynamics in Hispanic Patients With Pulmonary Arterial Hypertension

Cardiology Research

2024/4

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Anticoagulation in the Management of Acute Pulmonary Embolism—A Review

2024/3/12

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?

2024/3/5

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Statins and Venous Thromboembolic Disease-Where are we Now?

Current Vascular Pharmacology

2024/3/4

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Reduced-Dose Thrombolysis for Acute Pulmonary Embolism

Angiology

2024/3

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Chandra Ojha
Chandra Ojha

H-Index: 2

Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review

2024/3

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Chandra Ojha
Chandra Ojha

H-Index: 2

Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial Entity

2024/2/16

Karan Sarode
Karan Sarode

H-Index: 10

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review

2024/2

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Geoffrey D Barnes
Geoffrey D Barnes

H-Index: 18

Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies

2024/2

Evaluation of Four Validated Risk Scores to Predict Outcomes in Hispanic Patients With Acute Pulmonary Embolism

Angiology

2024/1/30

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Fluorenyl-tethered N-heterocyclic carbene (NHC): an exclusive C-donor ligand for heteroleptic calcium and strontium chemistry

Chemical Communications

2024

Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk

Current Vascular Pharmacology

2024

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease

Current Vascular Pharmacology

2024/1/1

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Risk Stratification Before Cardiac Surgery

American Journal of Cardiology

2024/1/1

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Association Between Blood Transfusion Treatment Strategy for Acute Coronary Syndromes and Clinical Outcomes: A Meta-analysis of Randomized Clinical Trials

American Journal of Therapeutics

2024/1/1

from albuminuria to uric acid–emerging risk factors beyond lipids

2023/7/1

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Influenza vaccination in mitigating vascular events and risk

2023/7/1

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion

Catheterization and Cardiovascular Interventions

2023/6

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

Low-Dose Alteplase versus Conventional Anticoagulation to treat Submassive Pulmonary Embolism in Hispanic Patients

International Journal of Angiology

2023/6

Yi Guo
Yi Guo

H-Index: 20

Debabrata Mukherjee
Debabrata Mukherjee

H-Index: 50

E-49| Moderate to High Precise-DAPT Score Is Associated With Increased Risk of Bleeding and Mortality in a Predominantly Hispanic Population

Journal of the Society for Cardiovascular Angiography & Interventions

2023/5/1

See List of Professors in Debabrata Mukherjee University(Texas Tech University)

Co-Authors

academic-engine